What Is NMN? Benefits, Evidence and Limitations
- , by SANUSq Research team
- 13 min reading time
What is NMN, and why is it suddenly everywhere in conversations about longevity? It is sold as a way to recharge your cells and slow the clock. The real picture is more modest and, in some ways, more interesting: striking results in mice, and human data that are still early, small and short.
What is NMN?
NMN stands for nicotinamide mononucleotide. It is a molecule your body makes for itself, mainly from forms of vitamin B3, and it is also present in very small amounts in foods such as edamame, broccoli, avocado and cabbage.
Its job is to act as a building block. The body turns NMN into NAD+ (nicotinamide adenine dinucleotide), a coenzyme that every cell depends on. In other words, NMN is a precursor: one step back in the chain that produces NAD+.
The idea behind NMN supplements fits in a sentence. NAD+ levels tend to fall as we get older, so supplying more of the raw material might help keep them up. Whether that translates into any real benefit for people is the open question, and it is where most of the debate sits.
The amounts in food are tiny compared with the doses used in studies, so diet alone won't give you anything close to a trial dose. NMN also has a close relative, nicotinamide riboside (NR), another NAD+ precursor that reaches the same destination by a slightly different route. Researchers are still comparing the two, and there is no clear winner.
NAD+: why it gets so much attention
NAD+ is not a fashionable ingredient. It is a basic part of how cells work. It helps the mitochondria turn food into usable energy, it is needed for repairing DNA, and it fuels a family of enzymes called sirtuins, which often appear in theories of how we age.
In a major review, Covarrubias et al. (2021) describe NAD+ as central to energy metabolism, DNA repair and immune cell function, and note that tissue NAD+ levels decline gradually with age in rodents and humans. They also stress that much remains to be learnt, including how best to restore NAD+, whether doing so is safe, and whether it brings any benefit to ageing humans.
Why does NAD+ fall? Two things seem to be happening at once. Production slows, and some enzymes that use up NAD+ become more active over the years, particularly in response to accumulated cell damage. The net result is a gradual decline, which is why NAD+ precursors such as NMN have attracted so much research interest.
The mouse studies behind the excitement
Much of the enthusiasm around NMN comes from animal research. In mice, NMN has improved a range of age-related measures, from metabolism and physical activity to blood vessel function.
Mills et al. (2016) gave NMN to normal mice for 12 months as they aged. The treated mice gained less weight with age, were more physically active and showed better insulin sensitivity, blood lipids and eye function than untreated mice, with no obvious toxicity.
These results are genuine and useful for science. But nutrition research is full of compounds that looked remarkable in rodents and disappointed in people. Mice live for two or three years, their metabolism runs differently from ours, and laboratory doses and conditions are tightly controlled. A longer, healthier life in a mouse is a reason to run human trials, not evidence that the same will happen in us. Many researchers in the field say openly that public interest has run well ahead of the clinical data.
NMN benefits in people: what human trials show
This is the part that matters most, so it's worth being precise. Human trials agree on one fairly solid point: NMN taken by mouth raises NAD+ levels in the blood, and over periods of a few weeks to a few months it has generally been well tolerated.
Reviewing the human evidence, Song et al. (2023) note that NAD+ in skin, blood, liver, muscle and brain is thought to fall with age, and that most studies of NMN have been carried out in cells or animals. They conclude that questions remain about its safety and physiological effects in humans, while around a dozen clinical trials were under way.
Beyond raising NAD+, the signals are weaker and less consistent. A few individual trials have reported changes worth following up:
In a 10-week randomised, placebo-controlled trial, Yoshino et al. (2021) found that NMN increased insulin sensitivity in the muscle of postmenopausal women with prediabetes who were overweight or obese. The study was small and the finding applies to that specific group.
Igarashi et al. (2022) gave 250 mg of NMN a day to healthy older men for 6 or 12 weeks. Blood NAD+ rose and the supplement was well tolerated. There were nominal improvements in walking speed and left-hand grip strength, which the authors said need confirming in larger studies, and no change in body composition.
In a 12-week randomised trial in 36 healthy middle-aged adults taking 250 mg a day, Katayoshi et al. (2023) found that NMN raised NAD+-related metabolites and caused no adverse events. Arterial stiffness tended to decrease, but the difference from placebo was not statistically significant.
Yi et al. (2023) randomised 80 healthy middle-aged adults to placebo or 300, 600 or 900 mg of NMN a day for 60 days. Blood NAD+ rose in all NMN groups, most at the two higher doses, no safety issues were found, and walking distance on a six-minute test improved more than with placebo. Insulin resistance did not change significantly.
When researchers pool the trials together, the picture becomes more sober.
A meta-analysis by Prokopidis et al. (2025) of randomised trials in adults with an average age over 60 found that NMN had no significant effect on muscle mass, grip strength, walking speed or chair-stand performance. The authors concluded that current evidence does not support NMN for preserving muscle mass and function in this age group.
A meta-analysis by Yang et al. (2026) of 15 trials, using 250–2,000 mg a day for between two weeks and 24 weeks, found that NMN did not increase adverse events or raise liver enzymes. It also found no significant effect on body weight, blood sugar, HbA1c, cholesterol or systolic blood pressure, with only a slight fall in diastolic blood pressure. The authors called for larger and longer trials.
The honest summary
The conclusion has two halves. Yes, NMN raises NAD+ in the blood and appears well tolerated in the short term. No, no human study so far shows that it slows ageing, extends life or prevents age-related disease. The trials are small, short and varied in design, and they mostly measure biological markers rather than outcomes you would feel in daily life.
A few reference points help to put this in proportion. Doses studied have ranged from about 250 mg to over 1,000 mg a day, usually for 4 to 12 weeks, mostly in middle-aged or older adults. What shows up reliably is a dose-related rise in blood NAD+ and good tolerance. Effects on walking, strength or metabolic markers come and go from one study to the next. That is the typical profile of a young field: solid biology, with clinical promise still to be confirmed.
Forms, doses and quality
The NMN market has grown quickly, and products vary widely. Daily amounts commonly range from around 250 to 900 mg, and the forms include capsules, powders and "sublingual" tablets, for which no clear advantage has been shown.
As with any trending ingredient, two problems tend to follow: marketing that outruns the science, and inconsistent quality between manufacturers, including purity, the true amount in each dose and the testing behind it. Treat any promise that sounds too good to be true with caution.
Regulatory status: worth knowing
This is the point advertising rarely mentions. NMN is not approved in the European Union: it is not an authorised novel food, so it cannot currently be sold there as a food or food supplement, and there is no authorised health claim for it. Its status in the UK is also unsettled. The United States is different. In September 2025 the US Food and Drug Administration (FDA) concluded that NMN can lawfully be sold as a dietary supplement, reversing its 2022 position. That decision is about whether NMN may be sold, not about whether it works: the FDA does not approve dietary supplements or their health claims before they go on sale.
If you are considering NMN, check the current position where you live rather than ordering blindly. That uncertainty is, in itself, a reason for patience.
Should you take NMN?
For now, NMN sits in a waiting room: interesting to researchers, well tolerated in short trials, but without any proven anti-ageing benefit in people. That is not a reason to dismiss it, but it is a reason to stay clear-headed about the claims made for it.
If your aim is to age well, the habits with the strongest evidence are neither new nor expensive: regular physical activity, including some strength work, enough sleep, a varied diet, managing stress and not smoking. Today they still do far more for your health than any fashionable powder.
If you are still curious about NMN, speak to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition or take regular medication, since long-term safety data are lacking.
One last reminder: in health, "new" and "promising" don't mean "proven". NMN may one day live up to some of its promise, or it may disappoint, as others have before it. Meanwhile, there is no rush, and plenty to gain from getting the basics right first.
Frequently asked questions
Does NMN make you younger?
No. No human study has shown that NMN makes people younger, slows ageing or extends life. It raises NAD+ levels in the blood, which is a biological marker, not evidence of turning back the clock.
Is NMN safe?
In trials lasting from a couple of weeks to around six months, NMN has generally been well tolerated, without a clear increase in side effects. Long-term safety data are missing, though, and its legal status varies between countries. Talk to a healthcare professional before trying it.
Are NMN and NAD+ the same thing?
No. NMN is a precursor, a building block that the body converts into NAD+. NAD+ is the coenzyme that actually does the work inside cells. Taking NMN is an attempt to support the body's own NAD+ production.
Can you raise NAD+ in other ways?
To some extent. Everyday habits such as physical activity, sleep and a balanced diet influence how the body makes and uses NAD+, at no cost and with no regulatory uncertainty. They remain the most solid foundation.
NMN or nicotinamide riboside (NR): which is better?
Both are NAD+ precursors that are being studied side by side. There is currently no strong evidence that either one is clearly better in people. Caution and professional advice are worth more than marketing arguments here.
Why is NMN talked about so much?
Because longevity research is booming and the results in mice have been eye-catching. The gap between mice and people remains large, however, and marketing often moves faster than the evidence.
References
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021;22(2):119–141. PMID 33353981
- Mills KF, Yoshida S, Stein LR, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metabolism. 2016;24(6):795–806. PMID 28068222
- Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Advances in Nutrition. 2023;14(6):1416–1435. PMID 37619764
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. PMID 33888596
- Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. 2022;8(1):5. PMID 35927255
- Katayoshi T, Uehata S, Nakashima N, et al. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial. Scientific Reports. 2023;13(1):2786. PMID 36797393
- Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29–43. PMID 36482258
- Prokopidis K, Moriarty F, Bahat G, McLean J, Church DD, Patel HP. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(3):e13799. PMID 40275690
- Yang W, Huang J, Tang Z, Chen C, Sun Y. Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation in adults: a systematic review and meta-analysis. Nutrients. 2026;18(14):2251. PMID 42514320
Read more on the blog
- What Are Antioxidants? →
- The Importance of CoQ10 for Your Health →
- Exercise for a Long and Healthy Life →
Watch on YouTube
Explore more on our channel, @SANUSqHealthSupplements.
We wish you good health on your terms.
The team at SANUSq.
PS. Curious what's currently on offer? Take a look at our latest promotions.
The health information in this article is provided for educational purposes only. Consult your healthcare professional before making any medical decisions.
Regulatory Notice
The information on our websites, blogs, and emails is provided for informational purposes only and has not been evaluated by the EMA, EFSA, or FDA. It is not intended to replace medical advice provided by your healthcare professional, and is not intended to diagnose, treat, cure, or prevent any disease. Our products are intended for adults aged 18 and over. While the vitamins and supplements mentioned may offer various health benefits, supplements and dietary changes should be considered part of an overall health plan and not a substitute for professional medical treatment. Only a qualified healthcare professional can provide personalized advice and treatment plans based on your individual health needs and medical history; you should consult your healthcare professional before taking any product(s) if you are pregnant or breastfeeding.